tradingkey.logo

Sophia Genetics SA

SOPH

3.320USD

+0.130+4.08%
收盤 09/19, 16:00美東報價延遲15分鐘
224.36M總市值
虧損本益比TTM

Sophia Genetics SA

3.320

+0.130+4.08%
關於 Sophia Genetics SA 公司
Sophia Genetics SA 是一家總部位於瑞士的公司,從事軟件出版行業。該公司提供基於雲的軟件即服務平臺 - SOPHiA DDM,這是一個數據驅動的醫療平臺,可以從不同的複雜數據集中獲取見解,以改善診斷、治療和藥物開發。該公司在瑞士、法國和英國設有辦事處,業務遍佈全球。
公司簡介
公司代碼SOPH
公司名稱Sophia Genetics SA
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
員工數量423
證券類型Ordinary Share
年結日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ Global Select Consolidated
國家Switzerland
郵編1180
電話41216941060
網址https://www.sophiagenetics.com/
公司代碼SOPH
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
60.38K
+51.32%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.60K
-5.14%
Mr. Milton G. Silva-Craig, J.D.
Mr. Milton G. Silva-Craig, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
Rest of EMEA
5.51M
31.00%
France
2.61M
14.70%
Italy
2.53M
14.23%
United States
2.48M
13.95%
Spain
1.42M
7.97%
其他
3.23M
18.15%
業務
地區
暫無數據
股東統計
更新時間: 8月18日 週一
更新時間: 8月18日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Alychlo NV
10.35%
Generation Investment Management LLP
10.05%
aMoon Fund
8.15%
Akre Capital Management, LLC
5.50%
Balderton Capital (UK) LLP
4.97%
其他
60.97%
持股股東
持股股東
佔比
Alychlo NV
10.35%
Generation Investment Management LLP
10.05%
aMoon Fund
8.15%
Akre Capital Management, LLC
5.50%
Balderton Capital (UK) LLP
4.97%
其他
60.97%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
16.13%
Venture Capital
13.13%
Family Office
10.40%
Individual Investor
6.46%
Investment Advisor
6.43%
Hedge Fund
1.48%
Bank and Trust
0.45%
Pension Fund
0.14%
Research Firm
0.03%
其他
45.34%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
89
36.69M
54.29%
-200.15K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
2023Q2
90
31.34M
48.19%
-3.70M
2023Q1
86
30.07M
46.79%
+1.58M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Alychlo NV
6.99M
10.46%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.16%
--
--
Mar 31, 2025
aMoon Fund
5.51M
8.25%
+577.36K
+11.70%
Feb 15, 2025
Akre Capital Management, LLC
3.72M
5.57%
+1.48M
+66.22%
Jun 20, 2025
Balderton Capital (UK) LLP
3.36M
5.03%
--
--
Feb 15, 2025
Camblong (Jurgi)
2.65M
3.97%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.31%
-32.20K
-1.44%
Mar 31, 2025
Principal Global Investors (Equity)
1.39M
2.07%
-43.33K
-3.03%
Mar 31, 2025
Millennium Management LLC
539.12K
0.81%
-159.51K
-22.83%
Mar 31, 2025
Ossipow (Vincent)
443.81K
0.66%
+48.31K
+12.21%
Feb 15, 2025
查看更多
持股ETF
更新時間: 9月2日 週二
更新時間: 9月2日 週二
機構名稱
佔比
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
佔比0%
Fidelity Nasdaq Composite Index ETF
佔比0%
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI